Tag: $Revolution Medicines

Revolution Medicines’ potential breakthrough pancreatic cancer drug succeeds in late-stage trial

Revolution Medicines’ drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, almost doubling the typical length of survival and slashing the risk of death by 60% versus chemotherapy, the company said Monday.

Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn

US pharmaceutical group Merck is in talks to buy Revolution Medicines, a cancer drugmaker with a market capitalisation of more than $20bn in what would be the latest big deal in the red-hot biotechnology sector.